Live Breaking News & Updates on Hans Scheurer

Stay updated with breaking news from Hans scheurer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ICYMI: Highlights From EHA 2023

The most-read articles from the 2023 European Hematology Association (EHA) Annual Meeting covered the most up-to-date treatment strategies for hematological malignancies, racial disparities in treatment patterns for blood cancers, and updates on immunotherapy as a tool in hematologic oncology. ....

Hans-scheurer , Workgroup-of-european-cancer-patient-advocacy-networks , European-hematology-association , Hematology-association , Annual-meeting , Term-data-show , Show-differences , Treatment-patterns , Oncology-move-beyond , Usual-disease , European-cancer-patient-advocacy-networks , Breaking-abstracts-offer-sneak-peek

Burgeoning Immunotherapy Options in Oncology Move Beyond CAR T and the Usual Disease States

The use of immune therapies for hematological malignancies is expanding beyond chimeric antigen receptor (CAR) T-cell therapies in the traditional lymphoid disease states, but the impact on patient quality of life must remain top of mind, according to speakers at the European Hematology Association 2023 Congress. ....

Germany , Sweden , Stockholm , Hermann-einsele , Hans-scheurer , Karolinska-institutet , Emma-morris , Stephan-mielke , Workgroup-of-european-cancer-patient-advocacy-networks , University-college-london , Morris , European-hematology-association